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Reply to the Editor:
We read with great interest the comments
of Dr Pocar and colleagues about the
article we recently published in The Jour-
nal of Thoracic and Cardiovascular Sur-
gery.1
It is mandatory for everyone involved
in cardiac surgery to know everything
about the reasons that have been men-
tioned in the first and second paragraphs
of their comments. We have previously
reported and underlined our policy re-
garding internal thoracic artery (ITA)
harvesting [. . .In order to optimize the
internal thoracic artery length, and avoid
the use of the most distal part of internal
thoracic artery (often small in diameter
and prone to spasm), we try to make the
internal thoracic artery graft as short as
possible. . .].2 According to this policy, it
was not a very distal part of the ITA that
was used for coronary-coronary bypass
grafting (CCBG). A crossclamp time of
41 minutes to perform 4 anastomoses on
coronary arteries is not too much, and for
the current level of myocardial protec-
tion, 10 minutes more means nothing.
As to the third reason, let us suppose
that ITA has been used to revascularize
the distal third of the left anterior de-
scending coronary artery (LAD), al-
though it did not have enough length as a
pedicled graft to reach the anastomotic
site. An aggressive form of atheroscle-
rotic disease would progress with time,
no matter that the coronary artery was
grafted with the ITA, because coronary
artery disease progress even if the tar-
geted artery was grafted with an arterial
graft (although to a lesser extent than if it
was grafted with vein graft).3 A new
proximal lesion on the LAD great enough
to jeopardize distal flow (through a cor-
onary-coronary bypass graft) would
probably be the reason to attempt the
revascularization (percutaneous coronary
intervention or redo coronary artery by-
798 The Journal of Thoracic and Cardiovapass grafting), even in the absence of a
coronary-coronary graft on the LAD, as
well as in the case that the ITA (eg, in
skeletonized fashion) was used in the first
operation.
I absolutely agree with Dr Pocar and
associates that anastomoses should ide-
ally be constructed to bypass the most
distal lesion, but it is obvious that with
CCBG over distal and single stenosis on
the LAD, we have done exactly what they
have underlined. Free ITA grafts yield
excellent patency rates of approximately
90% at 5 years,4 as well as at 7 years.5
We know that a major problem influenc-
ing early free ITA graft patency was re-
lated to construction of a proximal anas-
tomosis on the ascending aorta. In the
case of CCBG, we have a situation that a
segment of the free ITA graft at the site
of proximal anastomosis matches better
with the lower dp/dt of the LAD artery
than the ascending aorta. That is the rea-
son that we can expect an even better
patency rate over the years. There have
been only 2 cases of late angiography in
patients with coronary-coronary free ITA
grafts on the LAD (3 and 8 years after
surgical intervention) recording patent
coronary-coronary grafts.6
I agree with Dr Pocar and associates
that CCBG might at times be useful, and
that was in the reported case. We have
performed more than 25,000 cardiac pro-
cedures at our institution over 25 years. I
was the attending surgeon in more than
2500 cardiac procedures. Of more than
1600 procedures performed per year
(70% being coronary artery operations),
we have selected only 2 patients for
CCBG of a single distal lesion of the
large LAD (in the patients with multiple-
vessel disease). The other patient’s single
distal LAD lesion was grafted with a
short segment of the radial artery in
CCBG fashion.7 It means that our candi-
dates for CCBG procedure were selected
very carefully.
As to the fourth reason, when you have
to perform coronary surgery because of
multivessel disease, it does not make sense
to increase cost with implantation of a
drug-eluting stent, even in the countries
with great economic potential.
Finally, our intention was not to chal-
lenge the guidelines for coronary revascu-
larization but to underline that once in a
scular Surgery ● November 2004blue moon we can meet the patient who
does not fit in a guideline frame.
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Repair of the Ebstein anomaly
To the Editor:
I read with great interest the article by
Chen and colleagues1 “Early and Medium-
Term Results for Repair of Ebstein Anom-
aly.” The results are superb, without hos-
pital mortality and with improvement of
the functional condition. The technique
proved to be reproducible.
It seems from previous studies2 that the
Ebstein anomaly is a combination of ven-
tricular and valvular disease. This concept
has led my group to develop the use of an
associated bidirectional cavopulmonary
shunt in severe cases.3
I was surprised by the preoperative right
ventricular ejection function, which was
normal in all cases except 1 in Dr Chen’s
series, without quantified data.
My first concern is to know what is
meant by the right ventricle. Is it the effec-
